StockWatch
·
Pharmacy Retail
Quarterly Result4 Nov 2026, 08:31 pm

Entero Healthcare declares Unaudited Q2 FY27 Results

AI Summary

Entero Healthcare Solutions Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved the results, which were accompanied by an unmodified Limited Review Report from the statutory auditors. Additionally, the company noted the grant of 49,712 employee stock options under the 'Entero Employee Stock Option Plan 2023'. The trading window for securities will reopen 48 hours after the disclosure of these financial results.

Key Highlights

  • Unaudited financial results for Q2 FY27 declared.
  • Standalone and consolidated results approved by the Board.
  • Statutory auditors issued an unmodified review report.
  • 49,712 Employee Stock Options granted.
  • Trading window to reopen post-disclosure.